Profile data is unavailable for this security.
About the company
Tatva Chintan Pharma Chem Limited is an India-based specialty chemical manufacturing company. The Company is engaged in the manufacturing of verity of chemicals include structure directing agents (SDAs), phase transfer catalysts (PTCs), electrolyte salts for capacitor batteries, and pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC). Its SDAs are quarternary salts, which helps in the formation of channels and pores during the synthesis of zeolites. Its PTCs are used to facilitate the migration of a reactant from one phase into another phase where the reaction occurs in a heterogeneous multi-phase system. The Company operates two manufacturing facilities situated at Ankleshwar and Dahej in Bharuch, Gujarat, India. The Company is focused on serving various customers across various industries, including the automotive, petroleum, pharmaceutical, agro chemicals, paints and coatings, dyes and pigments, personal care and flavors and fragrances industries.
- Revenue in INR (TTM)3.94bn
- Net income in INR303.54m
- Incorporated1996
- Employees608.00
- LocationTatva Chintan Pharma Chem LtdPlot No. 353 G.I.D.C, MakarpuraVADODARA 390010IndiaIND
- Phone+91 7 574848533
- Websitehttps://www.tatvachintan.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gocl Corporation Ltd | 7.69bn | 570.72m | 20.28bn | 222.00 | 35.52 | -- | 29.41 | 2.64 | 11.52 | 11.52 | 155.23 | -- | -- | -- | -- | 34,656,330.00 | -- | 4.51 | -- | 5.31 | 23.01 | 27.61 | 7.42 | 19.41 | -- | -0.1333 | -- | 17.83 | 84.84 | 13.14 | 19.91 | 44.00 | -1.06 | 25.59 |
| Vishnu Chemicals Ltd | 12.48bn | 1.09bn | 20.32bn | 422.00 | 17.52 | -- | 14.48 | 1.63 | 17.70 | 17.70 | 200.84 | -- | -- | -- | -- | 29,577,610.00 | -- | 7.30 | -- | 12.94 | 30.05 | 35.31 | 8.73 | 6.53 | -- | 4.62 | -- | 2.80 | 30.12 | 16.35 | 67.78 | 56.77 | 28.86 | 14.87 |
| Sigachi Industries Ltd | 3.67bn | 494.13m | 21.64bn | 1.03k | 44.86 | -- | 36.87 | 5.89 | 1.47 | 1.47 | 11.07 | -- | -- | -- | -- | 3,551,738.00 | -- | 18.15 | -- | 24.63 | 52.78 | 49.43 | 13.45 | 15.12 | -- | 10.02 | -- | 0.00 | 20.68 | 24.43 | 8.74 | 49.64 | 87.10 | -- |
| Yasho Industries Ltd | 5.93bn | 579.34m | 21.68bn | 659.00 | 37.33 | 7.36 | 29.47 | 3.65 | 50.94 | 50.94 | 521.75 | 258.54 | 0.7223 | 2.51 | 5.32 | -- | 7.05 | 9.05 | 10.32 | 15.66 | 35.93 | 33.64 | 9.76 | 8.35 | 0.5962 | 5.65 | 0.6627 | -- | -11.61 | 11.78 | -14.63 | 37.26 | 58.12 | -- |
| IOL Chemicals and Pharmaceuticals Ltd. | 21.33bn | 1.34bn | 21.96bn | 2.56k | 16.33 | 1.36 | 11.13 | 1.03 | 22.90 | 22.90 | 363.33 | 274.49 | 0.9998 | 3.72 | 4.37 | -- | 6.30 | 14.91 | 8.27 | 19.45 | 34.50 | 34.79 | 6.30 | 12.00 | 1.24 | 10.41 | 0.0199 | -- | -3.80 | 4.82 | -3.39 | -10.70 | 35.27 | -- |
| Bhagiradha Chemicals and Industries Ltd | 4.19bn | 203.95m | 22.01bn | 467.00 | 92.06 | -- | 70.74 | 5.25 | 1.92 | 1.92 | 38.89 | -- | -- | -- | -- | 8,971,398.00 | -- | 8.84 | -- | 14.38 | 38.85 | 25.76 | 4.87 | 6.84 | -- | 5.12 | -- | -- | 15.25 | 21.88 | 26.31 | -- | 26.58 | -- |
| Foseco India Ltd | 4.89bn | 745.94m | 22.49bn | 225.00 | 30.15 | -- | 27.10 | 4.60 | 116.80 | 116.80 | 765.70 | -- | -- | -- | -- | -- | -- | 13.76 | -- | 19.82 | 45.75 | 39.26 | 15.25 | 11.35 | -- | 671.05 | -- | 32.91 | 17.38 | 5.68 | 58.77 | 17.90 | 9.29 | 0.00 |
| Astec LifeSciences Limited | 4.58bn | -469.30m | 23.15bn | 551.00 | -- | 6.27 | -- | 5.05 | -23.94 | -23.94 | 234.09 | 188.32 | 0.4689 | 1.30 | 2.83 | -- | -4.80 | 4.71 | -9.10 | 9.73 | 30.32 | 30.66 | -10.23 | 6.38 | 0.5102 | -1.67 | 0.572 | -- | -27.06 | 1.24 | -283.57 | -- | 20.75 | -- |
| India Glycols Ltd | 74.98bn | 1.71bn | 24.51bn | 1.28k | 14.32 | -- | 8.91 | 0.3268 | 55.26 | 55.26 | 2,421.80 | -- | -- | -- | -- | 58,398,440.00 | -- | 3.79 | -- | 6.66 | 10.56 | 10.73 | 2.28 | 2.71 | -- | 2.85 | -- | 12.44 | 0.6095 | 9.80 | -62.05 | 5.32 | 27.64 | 13.40 |
| Tatva Chintan Pharma Chem Ltd | 3.94bn | 303.54m | 25.73bn | 608.00 | 82.65 | 3.49 | 45.99 | 6.54 | 13.31 | 13.31 | 171.88 | 315.10 | 0.4989 | 1.10 | 5.10 | -- | 3.85 | 10.54 | 4.82 | 14.61 | 55.74 | 46.39 | 7.71 | 14.43 | 1.82 | 6.52 | 0.019 | 5.17 | -7.11 | 13.79 | -33.27 | 8.12 | 67.37 | -- |
| Premier Explosives Limited | 2.37bn | 240.15m | 25.83bn | 822.00 | 107.63 | -- | 73.61 | 10.89 | 22.32 | 22.32 | 220.46 | -- | -- | -- | -- | 2,886,219.00 | -- | 0.159 | -- | 0.2292 | 62.03 | 47.02 | 10.14 | 0.2542 | -- | 3.67 | -- | -- | 1.46 | -6.34 | 30.32 | -3.25 | -1.93 | -7.42 |
| Thirumalai Chemicals Ltd | 20.83bn | -387.90m | 27.08bn | 526.00 | -- | 2.36 | 110.92 | 1.30 | -3.79 | -3.79 | 203.73 | 111.90 | 0.7334 | 5.84 | 14.61 | -- | -1.37 | 5.26 | -2.05 | 7.52 | 20.12 | 26.26 | -1.86 | 5.64 | 0.8583 | -0.292 | 0.522 | 19.92 | -2.30 | 10.56 | -143.18 | -- | 33.22 | -12.94 |
| India Pesticides Ltd | 7.52bn | 891.33m | 28.54bn | 280.00 | 31.91 | -- | 27.63 | 3.79 | 7.77 | 7.77 | 65.60 | -- | -- | -- | -- | 26,866,790.00 | -- | -- | -- | -- | 41.48 | -- | 11.85 | -- | -- | 24.73 | -- | -- | 23.57 | -- | -9.32 | -- | -- | -- |
Data as of May 18 2024. Currency figures normalised to Tatva Chintan Pharma Chem Ltd's reporting currency: Indian Rupee INR
15.26%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 30 Apr 2024 | 1.38m | 5.90% |
| SBI Funds Management Ltd.as of 30 Apr 2024 | 648.17k | 2.77% |
| Goldman Sachs Asset Management LPas of 29 Feb 2024 | 523.76k | 2.24% |
| ICICI Prudential Asset Management Co. Ltd.as of 30 Apr 2024 | 461.94k | 1.98% |
| Mirae Asset Investment Managers (India) Pvt Ltd.as of 30 Apr 2024 | 383.35k | 1.64% |
| PGIM India Asset Management Pvt Ltd.as of 30 Apr 2024 | 121.05k | 0.52% |
| BlackRock Advisors (UK) Ltd.as of 02 Apr 2024 | 24.00k | 0.10% |
| BlackRock Fund Advisorsas of 04 Apr 2024 | 18.06k | 0.08% |
| TIAA-CREF Investment Management LLCas of 31 Mar 2024 | 6.43k | 0.03% |
| State Street Global Advisors Ltd.as of 04 Apr 2024 | 2.88k | 0.01% |
More ▼
Data from 31 Dec 2023 - 09 May 2024Source: FactSet Research Systems Inc.
